Abstract:
The present invention relates to a detection method using magnetic nanoparticles for rapidly isolating Mycobacterium avium subsp. paratuberculosis from fecal samples and, more specifically, to a method for detecting the Mycobacterium avium subsp. paratuberculosis which isolates the Mycobacterium avium subsp. paratuberculosis with high sensitivity which can be existed in animal fecal samples using the magnetic nanoparticles to which Mycobacterium avium subsp. paratuberculosis specific antibodies are combined and rapidly and simply checks infection of the Mycobacterium avium subsp. paratuberculosis by performing polymerase chain reaction using primers which are specifically combined to DNA of the Mycobacterium avium subsp. paratuberculosis. According to the present invention, the detection method using the magnetic nanoparticles for rapidly isolating the Mycobacterium avium subsp. paratuberculosis from fecal samples can easily detect the Mycobacterium avium subsp. paratuberculosis even if small number of the Mycobacterium avium subsp. paratuberculosis is existed in biological samples such as feces and prevent contagion to different entities by isolating the infected entities from an allied army by performing the method simply and rapidly.
Abstract:
A DNA chip is provided to evaluate the harm to human body caused by changing of human flora, which is prepared by identifying and selecting 90 kinds of genes which significantly react to the change of the human flora in colon crypt cell of human flora-associated mice and amplifying and purifying the genes. The DNA chip for detecting specific reaction of human flora comprises at least one gene selected from a gene table(A) attached to a substrate, wherein the gene table(A) consists of Dap3, Rpa1, Ccnd2, Cdc45l, Gmnn, Cul4b, Tacc2, Bnip3l, Slc26a1, Ddx1, Cacnb3, Rpl27, Slc22a1l, Cav, Tuba4, Lrp10, Mt-1, Tiam2, Zdhhc3, Rhcg, Ipo4, 2610529I12Rik, Igj, Daf1, Il18, Tnfsf13b, Prkiri, Serping1, Eif2ak3, Mpp1, Lnx1, 4732481h14Rik, Rgs12, Dcamkl1, Mllt1, Per1, Keap1, Hdac5, Ncoa6, Crem, Crsp7, Rnf12, Alas1, Cotl11, Gstm2, Siat9, 5430437P03Rik, Purb, Col3a1, Il16, Mut, 6330590F17Rik, Srpk2, Klf3, Cited1, D230019K24Rik,, Ugcg, Au043625, Rw1-pending, Hsd17b2, 5031404N19, Tccr, Npm1, Sh3glb2, Aldh6a1, Plp, Ptgs1, Fads3, Parva, C130039O16, Epc1, CPd, Mtmr7, 4930455F23Rik, Rab6ip1, Mcpt4, Fn3k, 1110037F02Rik, 1110038M16Rik, 170012H12H17Rik, Thsd1, 98301480O20Rik, Ptgs2, Tcp11, Guca1a, Usp15, Ybx2, Tcl1, Cldn8 and Ckap2. The method comprises the steps of: (a) reacting the DNA chip with RNA which is collected from colon crypt cells and amplified; and (b) investigating the gene expression degree of the DNA chip.
Abstract:
The present invention relates to a complete induced pluripotent stem cell obtained by treating sodium butyrate and a treating method thereof which contain a process of treating the sodium butyrate onto the complete induced pluripotent stem cell. According to the present invention, the production method can be effectively used for research of the relevant fields, as a partial induced pluripotent stem cell having an interval characteristic of a somatic cell and a stem cell can be efficiently converted into the complete induced pluripotent stem cell.
Abstract:
The present invention relates to a marker composition for diagnosis of bone marrow cancer and a kit and a method for diagnosis of bone marrow cancer including the marker. The marker composition of the present invention amplifies a certain area where CpG area of the gene BCL11a, RB1, GLIS2 and ABI2 is included, in order to compare similarities and differences of the methylation level of the gene. Hence, the present invention can effectively be used to promptly and accurately diagnose bone marrow cancer including T-cell lymphoma, B-cell lymphoma and leukemia.
Abstract:
PURPOSE: A monoclonal antibody with improved binding specificity and affinity and a kit for detecting aflatoxin B1 are provided to enhance purification efficiency and detection intensity. CONSTITUTION: A conjugate comprises aflatoxin B1, a linker, and a carrier protein. The mole ratio of aflatoxin B1 and carrier protein is 1:5.5-1:6.5, respectively. The carrier protein is Bovine Serum Albumin(BSA), KLH(keyhole limpet hemocyanin), or ovalbumin. A kit for detecting aflatoxin B1 contains the monoclonal antibody.
Abstract:
PURPOSE: A monoclonal antibody with improved binding specificity and affinity and a kit for detecting aflatoxin B1 are provided to enhance purification efficiency and detection intensity. CONSTITUTION: A conjugate comprises aflatoxin B1, a linker, and a carrier protein. The mole ratio of aflatoxin B1 and carrier protein is 1:5.5-1:6.5, respectively. The carrier protein is Bovine Serum Albumin(BSA), KLH(keyhole limpet hemocyanin), or ovalbumin. A kit for detecting aflatoxin B1 contains the monoclonal antibody.
Abstract:
PURPOSE: A monoclonal antibody with improved binding specificity and affinity and a kit having the same for detecting zearalenone are provided to effectively remove zearalenone contamination in feed or food. CONSTITUTION: A conjugate contains zearalenone, linker, and carrier protein. The mole ratio of the zearalenone and carrier protein is 1:22-1:26. The carrier protein is bovine serum albumin. A monoclonal antibody of deposit number KCLRF-BP-00207 is produced by inputting the conjugate to a mouse. A kit for detecting KCLRF-BP-00207 contains the monoclonal antibody.